Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK).
Vaccines (Basel). 2022 Sep 23;10(10):1601. doi: 10.3390/vaccines10101601.
Vaccines (Basel). 2022.
PMID: 36298466
Free PMC article.
Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study.
Vivaldi G, Jolliffe DA, Faustini S, Shields AM, Holt H, Perdek N, Talaei M, Tydeman F, Chambers ES, Cai W, Li W, Gibbons JM, Pade C, McKnight Á, Shaheen SO, Richter AG, Martineau AR.
Vivaldi G, et al.
J Infect Dis. 2022 Nov 28;226(11):1903-1908. doi: 10.1093/infdis/jiac321.
J Infect Dis. 2022.
PMID: 35906930
Free PMC article.
Item in Clipboard
Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK).
Vivaldi G, Jolliffe DA, Holt H, Tydeman F, Talaei M, Davies GA, Lyons RA, Griffiths CJ, Kee F, Sheikh A, Shaheen SO, Martineau AR.
Vivaldi G, et al.
Lancet Reg Health Eur. 2022 Sep 23;22:100501. doi: 10.1016/j.lanepe.2022.100501. eCollection 2022 Nov.
Lancet Reg Health Eur. 2022.
PMID: 36168404
Free PMC article.
Item in Clipboard
Cite
Cite